283 related articles for article (PubMed ID: 23169395)
1. The prognostic value of E-cadherin in gastric cancer: a meta-analysis.
Xing X; Tang YB; Yuan G; Wang Y; Wang J; Yang Y; Chen M
Int J Cancer; 2013 Jun; 132(11):2589-96. PubMed ID: 23169395
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 expression and patient survival in gastric cancer: a systematic review of the literature with meta-analysis.
Cheng H; Wang X; Li T; Chen L
Med Oncol; 2015 Jan; 32(1):389. PubMed ID: 25428392
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical study of E-cadherin expression with correlations to clinicopathological features in gastric cancer.
Shun CT; Wu MS; Lin JT; Wang HP; Houng RL; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1998; 45(22):944-9. PubMed ID: 9755986
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin expression as a prognostic factor in patients with ovarian cancer: a meta-analysis.
Dai C; Cao J; Zeng Y; Xu S; Jia X; Xu P
Oncotarget; 2017 Oct; 8(46):81052-81061. PubMed ID: 29113366
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic and Clinicopathological Significance of Tumor-Associated Macrophages in Patients with Gastric Cancer: A Meta-Analysis.
Yin S; Huang J; Li Z; Zhang J; Luo J; Lu C; Xu H; Xu H
PLoS One; 2017; 12(1):e0170042. PubMed ID: 28081243
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of pSTAT3 in gastric cancer: a meta-analysis.
Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
J Cancer Res Clin Oncol; 2016 Mar; 142(3):649-57. PubMed ID: 26233579
[TBL] [Abstract][Full Text] [Related]
7. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.
Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS
J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of Muc5AC in gastric cancer: A meta-analysis.
Zhang CT; He KC; Pan F; Li Y; Wu J
World J Gastroenterol; 2015 Sep; 21(36):10453-60. PubMed ID: 26420972
[TBL] [Abstract][Full Text] [Related]
9. The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: A meta-analysis.
Yang Y; Gao P; Song Y; Sun J; Chen X; Zhao J; Ma B; Wang Z
Eur J Surg Oncol; 2016 Aug; 42(8):1176-82. PubMed ID: 27293109
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis.
Soleyman-Jahi S; Nedjat S; Abdirad A; Hoorshad N; Heidari R; Zendehdel K
PLoS One; 2014; 10(4):e0122316. PubMed ID: 25919283
[TBL] [Abstract][Full Text] [Related]
11. Lymph node micrometastases is a poor prognostic factor for patients in pN0 gastric cancer: a meta-analysis of observational studies.
Li Y; Du P; Zhou Y; Cheng Q; Chen D; Wang D; Sun T; Zhou J; Patel R
J Surg Res; 2014 Oct; 191(2):413-22. PubMed ID: 25060322
[TBL] [Abstract][Full Text] [Related]
12. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
[TBL] [Abstract][Full Text] [Related]
13. Vimentin immunohistochemical expression as a prognostic factor in gastric cancer: A meta-analysis.
Yin S; Chen FF; Yang GF
Pathol Res Pract; 2018 Sep; 214(9):1376-1380. PubMed ID: 30078472
[TBL] [Abstract][Full Text] [Related]
14. [Expression of ALDH1, CXCR4 and E-cadherin in castric carcinoma and their roles in lymphatic metastasis].
Zhao Y; Jin X; Li N; Li J; Qian J
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1390-1395. PubMed ID: 27777204
[TBL] [Abstract][Full Text] [Related]
15. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer.
Zhong XY; Zhang LH; Jia SQ; Shi T; Niu ZJ; Du H; Zhang GG; Hu Y; Lu AP; Li JY; Ji JF
Histopathology; 2008 Apr; 52(5):560-8. PubMed ID: 18312357
[TBL] [Abstract][Full Text] [Related]
16. Abnormal β-catenin immunohistochemical expression as a prognostic factor in gastric cancer: a meta-analysis.
Li LF; Wei ZJ; Sun H; Jiang B
World J Gastroenterol; 2014 Sep; 20(34):12313-21. PubMed ID: 25232267
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis: E-cadherin immunoexpression as a potential prognosis biomarker related to gastric cancer metastasis in Asian patients.
Li T; Chen J; Liu QL; Huo ZH; Wang ZW
Eur Rev Med Pharmacol Sci; 2014; 18(18):2693-703. PubMed ID: 25317805
[TBL] [Abstract][Full Text] [Related]
18. Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma.
Li Y; Chen CQ; He YL; Cai SR; Yang DJ; He WL; Xu JB; Zan WH
J Surg Oncol; 2012 Sep; 106(3):304-10. PubMed ID: 22231933
[TBL] [Abstract][Full Text] [Related]
19. Poor prognosis of phosphatase of regenerating liver 3 expression in gastric cancer: a meta-analysis.
Hu L; Luo H; Wang W; Li H; He T
PLoS One; 2013; 8(10):e76927. PubMed ID: 24204707
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis.
Lu L; Wu M; Zhao F; Fu W; Li W; Li X; Liu T
Oncotarget; 2016 Oct; 7(42):69087-69096. PubMed ID: 27634907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]